Your browser doesn't support javascript.
loading
Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score system.
Prelaj, Arsela; Proto, Claudia; Lo Russo, Giuseppe; Signorelli, Diego; Ferrara, Roberto; Mensah, Mavis; Galli, Giulia; De Toma, Alessandro; Viscardi, Giuseppe; Brambilla, Marta; Lobefaro, Riccardo; Trevisan, Benedetta; Trovò, Francesco; Torri, Valter; Sozzi, Gabriella; Garassino, Marina Chiara; Boeri, Mattia.
Afiliación
  • Prelaj A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Proto C; Department of Electronics, Information, and Bioengineering, Polytechnic University of Milan, Milano, Italy.
  • Lo Russo G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Signorelli D; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Ferrara R; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Mensah M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Galli G; Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • De Toma A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Viscardi G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Brambilla M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Lobefaro R; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Trevisan B; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Trovò F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Torri V; Department of Electronics, Information, and Bioengineering, Polytechnic University of Milan, Milano, Italy.
  • Sozzi G; Pharmacological Research Institute IRCSS Mario Negri, Milano, Italy.
  • Garassino MC; Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Boeri M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Transl Lung Cancer Res ; 9(3): 617-628, 2020 Jun.
Article en En | MEDLINE | ID: mdl-32676324
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Transl Lung Cancer Res Año: 2020 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Transl Lung Cancer Res Año: 2020 Tipo del documento: Article País de afiliación: Italia